Rockville, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)BioHealth Innovation, founded in 2011, is a community nonprofit in the Medical Research sector that reported $4.6M in total revenue in fiscal year 2023. Revenue grew 14% year-over-year, indicating healthy expansion. Expenses of $4.4M left a modest 6% surplus.
Biohealth Innovation connects market relevant research assets to appropriate funding, management, and markets to facilitate the development of commercially viable bio health products and companies.
Entrepreneur-in-Residence/Small Business Innovative Research (SBIR): The BHI SBIR/STTR federal funding assistance offers BioHealth companies support in preparing applications for federal funding...
Entrepreneur-in-Residence/Small Business Innovative Research (SBIR): The BHI SBIR/STTR federal funding assistance offers BioHealth companies support in preparing applications for federal funding inclusive of SBIRS, STTRS, and other federal government awards. BHI's Entrepreneur-in-Residence (EIR) program is designed to be an active partner with research institutions to source, fund, and grow high-potential, early-stage products through project-focused companies. The entrepreneurs in the program support the formation of new companies based upon innovative discoveries in the areas of drugs, vaccines, therapeutics, diagnostics, and medical devices from the intramural research programs at partner organizations, as well as from universities and businesses. The EIR will find, evaluate, and support the development of new start-up companies based upon technology license agreements from technology transfer offices or equivalent units within the research institutions. Under an NIH/OTT partnership intermediary agreement, BHI will employ and place entrepreneurs-in-residence (EIR) within OTT to evaluate, identify and license intramural technologies in the areas of drugs, vaccines, therapeutics, diagnostics and medical devices from the intramural research programs at both the NIH and the Food and Drug Administration (FDA). An NIH EIR is an industry expert with scientific, entrepreneurial/managerial and financial experience who works side by side with NIH scientists to identify, evaluate and support the development of new start-up companies based upon technology license agreements from OTT. The innovate UMBC program provides applied training for post-doctoral fellows, research scientists, and other professionals who want to start life science-based companies. The program was launched in 2010 with a 3-year funding grant from the National Science Foundation (NSF). The university of Maryland, Baltimore County (UMBC) will offer the program at the universities at shady grove's campus in Montgomery County, Maryland. The program is intended for scientists interested in commercializing biomedical technology. Partners in the program are biohealth innovation, inc. And the Montgomery County department of economic development.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $4,643,952 | $4,065,006 | +0.1% |
| Expenses | $4,364,948 | $3,686,773 | +0.2% |
| Net Income | $279,004 | $378,233 | -0.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Richard Bendis | President & CEO | 40.00 |
Officer
Director
|
$523,278 | $42,996 | $566,274 |
| Pete Briskman | Chair | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| Christine Dingivan | Vice Chair | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| Charles Morton | Secretary | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| Dave Lemus | Treasurer | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| Sally Allain | Board Member | 2.00 |
Director
|
$0 | $0 | $0 |
| Jarrod Borkat | Board Member | 2.00 |
Director
|
$0 | $0 | $0 |
| Christopher Callaghan | Board Member | 2.00 |
Director
|
$0 | $0 | $0 |
| Donna Edmonds | Board Member | 2.00 |
Director
|
$0 | $0 | $0 |
| William Hearl | Board Member | 2.00 |
Director
|
$0 | $0 | $0 |
| Juergen Klenk | Board Member | 2.00 |
Director
|
$0 | $0 | $0 |
| Anthony Lakavage | Board Member | 2.00 |
Director
|
$0 | $0 | $0 |
| Joel Marcus | Board Member | 2.00 |
Director
|
$0 | $0 | $0 |
| Kurt Newman | Board Member | 2.00 |
Director
|
$0 | $0 | $0 |
| Jay Perman | Board Member | 2.00 |
Director
|
$0 | $0 | $0 |
| John Sackett | Board Member | 2.00 |
Director
|
$0 | $0 | $0 |
| Aubrey Watkins | Board Member | 2.00 |
Director
|
$0 | $0 | $0 |
| Srjuana Cherukuri | Board Member (MAR-DEC) | 2.00 |
Director
|
$0 | $0 | $0 |
| Ronald Kurz | Board Member (MAY-DEC) | 2.00 |
Director
|
$0 | $0 | $0 |
| Tyrell Rivers | Board Member (MAY-DEC) | 2.00 |
Director
|
$0 | $0 | $0 |
| Raymond Blanchard | Board Member (JUN-DEC) | 2.00 |
Director
|
$0 | $0 | $0 |
| Dan Mallon | Board Member (JUN-DEC) | 2.00 |
Director
|
$0 | $0 | $0 |
| Aime Smart | Board Member (AUG-DEC) | 2.00 |
Director
|
$0 | $0 | $0 |
| Steven Roberts | Board Member (SEPT-DEC) | 2.00 |
Director
|
$0 | $0 | $0 |
| Ethel Rubin | Entrepreneur in Residence | 40.00 |
Highest
|
$269,185 | $13,459 | $282,644 |
| John Sullivan | Entrepreneur in Residence | 40.00 |
Highest
|
$235,827 | $7,515 | $243,342 |
| Lynne Brisbane | VP of Finance, Operations, | 40.00 |
Highest
|
$170,676 | $5,152 | $175,828 |
| Monique Bennett | Sr. Life Science Business Strategist | 40.00 |
Highest
|
$108,580 | $3,296 | $111,876 |
| Olivia Myer | Entrepreneur in Residence | 40.00 |
Highest
|
$100,043 | $3,030 | $103,073 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $4,643,952 | $4,364,948 | $5,807,113 | $279,004 |
| 2022 | $4,065,006 | $3,686,773 | $5,438,812 | $378,233 |
| 2021 | $3,804,025 | $3,195,203 | $5,134,155 | $608,822 |
| 2020 | $2,643,861 | $2,940,887 | $4,546,927 | $-297,026 |
| 2019 | $2,970,268 | $3,046,056 | $4,621,497 | $-75,788 |
| 2018 | $2,692,350 | $3,051,879 | $4,765,620 | $-359,529 |
Compare BioHealth Innovation with other nonprofits in Maryland and across the country.